Pfizer Inc. et al. v. Novo Nordisk A/S et al. > Summary
Court Case Number IPR2020-00324
Filing Date Dec 19, 2019
Institution Decision Date Jun 23, 2020
Decision Date Jun 21, 2021
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesErica A. Franklin
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
Petitioner
Patent Owner
Petitioner Attorneys
8Pfizer
Attorney Name: Thomas J. Meloro
Willkie Farr & Gallagher
Pfizer
Attorney Name: Michael W. Johnson
Willkie Farr & Gallagher
Pfizer
Attorney Name: Emily J. Greb
Perkins Coie
Pfizer
Attorney Name: Brandon M. White
Perkins Coie
Pfizer
Attorney Name: Lara J. Dueppen
Perkins Coie
Pfizer
Attorney Name: Jovial Wong
Winston & Strawn
Pfizer
Attorney Name: Sharon Lin
Winston & Strawn
Pfizer Legal Division 2
Attorney Name: Laird Forrest
Perkins Coie
Patent Owner Attorneys
6Novo Nordisk
Attorney Name: Jeffrey J. Oelke
Fenwick & West LLP
Novo Nordisk
Attorney Name: Ryan Johnson
Fenwick & West LLP
Novo Nordisk
Attorney Name: Laura Moran
Fenwick & West LLP
Novo Nordisk
Attorney Name: Peter Tessier
Fenwick & West LLP
Novo Nordisk
Attorney Name: Tina Bjeldskov Pedersen
Fenwick & West LLP
Novo Nordisk
Attorney Name: Dorthe Kot Engelund
Novo Nordisk
Related Patents
Doc No | Title | Issue date |
---|---|---|
08114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices | Feb 14, 2012 |